Several Manifestations of Micro-Pathological Nephrotic Syndrome
2018-09-16 10:08
The clinical manifestation of the micro-pathological nephrotic syndrome is nephrotic syndrome, i.e. massive proteinuria, hypoproteinemia, edema, hyperlipidemia, etc. The age of onset of MCN is more common in children and adolescents, and often occurs in children under the age of 10, with a peak of 2 – 4 years. The aim of the treatment of this disease is to induce and alleviate the adverse reactions of drugs as soon as possible, that is, to use a dose of drugs that produces the least adverse reactions, so as to maintain the remission state of patients as long as possible.
Micropathological nephrotic syndrome can be divided into primary and secondary types, the primary cause of which is unknown. Recent studies, especially on glomerular podocytes, have found that podocytes are the main target cells of micro-pathological nephropathy, and they are listed as the most representative podocytosis. The incidence of secondary MCD and non-steroidal anti-inflammatory drugs, allergic factors, blood system tumors such as lymphoma, chronic leukemia and so on can also lead to micro-pathological nephrotic syndrome.
The aim of the treatment of micro-pathological nephrotic syndrome is to induce and alleviate the adverse reactions of drugs as soon as possible, that is, to use a dose of drugs that produces the least adverse reactions, so as to maintain the remission state of patients as long as possible. Micro – pathological nephrotic syndrome is best treated by combining traditional Chinese and western medicine.
After you know more information above you can get more benefit from it and avoid further damage to your health ,if you want to know more message about gout please consult us through the following message:
E-mail: kidney-treatment@hotmail.com
- Tag: Clinical manifestations Micro-pathological nephrotic syndrome Adverse reactions
- Pre: Some Harms Of Kidney insufficiency May affect Other Functions
- Next: The Complications Of Nephrotic Syndrome Should Be Attention